Back to search
FDAFDA · Food and drugs·Recall number D-1130-2019

Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01

Published April 17, 2019 · Recall initiated: March 25, 2019

Summary

FDA records drug Class II recall D-1130-2019, published April 17, 2019 and initiated March 25, 2019. Recalling firm: Lohxa LLC; Status: Terminated; Reported quantity: 5 boxes - 250 unit dose cups.; Lot: Lot#: M030042P, Exp. 01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lohxa LLC
Distributor
MA, NY and WY
Lot
Lot#: M030042P, Exp. 01/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01 recalled?

Yes. FDA published recall D-1130-2019 on April 17, 2019. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

What should I do if I have this product?

Voluntary: Firm initiated · Letter